by Isogenica Webmaster | Dec 2025 | VHH Resources
CIS Display™️: a fully in vitro platform for enhancing small-format discovery Today, there are many display technologies in the market. The yeast and mammalian display, for example, are good for complex scaffolds, but they struggle with displaying large libraries. In... by Isogenica Webmaster | May 2025 | VHH Resources
Protein & Antibody Engineering Summit VHH as Building Blocks for Immune and Tumour This webinar “Protein & Antibody Engineering Summit VHH as Building Blocks for Immune and Tumour” was presented at PEGS Europe... by Isogenica Webmaster | Feb 2025 | VHH Resources
On-demand webinar: “Small modalities, deep impact”: VHH antibodies as complementary approaches for challenging therapeutic targets This webinar was held in collaboration with AXXAM About this webinar: Since 2019, small antibodies known as VHHs have been growing...
by Philippa Shelton | Feb 2025 | Blogs, VHH Resources, VHHs
From monoclonals to bi-specifics: Harnessing the transformative power of VHHs to supercharge IgG therapeutics Updated on Feb. 16th, 2025 – Since their discovery over thirty years ago, monoclonal antibodies (mAbs) based on Immunoglobulin G (IgG) have...
by Isogenica Webmaster | Sep 2023 | Blogs, VHH Resources, VHHs
On the Origin of VHHs: Student serendipity and coincidental camels At Isogenica, we’re experts in discovering and developing VHHs – small format single chain antibodies. Unlike conventional IgG antibodies from humans or mice, VHHs (also known as nanobodies) are...